◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › P › PACB

Pacific Biosciences of California (PACB) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-10-03

Pacific Biosciences of California (PACB) operates in the MEDICAL DEVICES industry and is headquartered in Menlo Park, United States with about 485 employees. Its market capitalization is roughly $810 million. In the fiscal year ended 2025-12-31, PACB reported $160M in revenue and ($546M) in net income.

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems.

Interactive charts & full statements → Open the PACB valuation workbench →

PACB Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31
Total Revenue	$159M	$160M	$154M	$201M	$128M	$131M	$79M	$91M	$79M	$93M	$91M	$93M	$61M	$28M	$26M	$34M	$2M	$0M	$1M	$2M
Gross Profit	$58M	$51M	$37M	$53M	$49M	$59M	$33M	$35M	$25M	$35M	$44M	$53M	$23M	$6M	$1M	$13M	$2M	$0M	$1M	$2M
Gross Margin %	36.5%	31.7%	24.2%	26.3%	38.2%	45.1%	41.3%	38.0%	31.9%	37.1%	48.7%	57.6%	38.6%	22.8%	3.6%	38.5%	100.0%	100.0%	100.0%	100.0%
Operating Income (EBIT)	($163M)	($558M)	($474M)	($334M)	($307M)	($210M)	($104M)	($101M)	($101M)	($90M)	($71M)	($29M)	($63M)	($78M)	($94M)	($110M)	($140M)	($88M)	($45M)	($23M)
Operating Margin %	-102.5%	-348.5%	-308.0%	-166.8%	-239.4%	-161.2%	-132.3%	-110.6%	-128.4%	-96.1%	-78.5%	-31.4%	-103.7%	-275.2%	-363.1%	-324.1%	-8377.2%	-65237.0%	-4973.2%	-1081.4%
Net Income	($131M)	($546M)	($310M)	($307M)	($314M)	($181M)	$29M	($84M)	($103M)	($92M)	($74M)	($32M)	($66M)	($79M)	($94M)	($109M)	($140M)	($88M)	($44M)	($22M)
Net Margin %	-82.4%	-341.5%	-201.2%	-153.0%	-244.9%	-138.8%	37.3%	-92.6%	-130.4%	-98.6%	-82.0%	-34.2%	-109.2%	-281.4%	-363.6%	-323.0%	-8373.1%	-64965.2%	-4856.2%	-994.8%
EBITDA	($109M)	($34M)	($243M)	($271M)	($282M)	($251M)	$39M	($72M)	($93M)	($81M)	($67M)	($25M)	($59M)	($71M)	($88M)	($103M)	($135M)	($84M)	($42M)	($22M)
Earnings Per Share (EPS)	$-0.43	$-1.82	$-1.07	$-1.21	$-1.40	$-0.89	$0.17	$-0.55	$-0.76	$-0.87	$-0.83	$-0.42	$-0.94	$-1.26	$-1.69	$-2.03	$-5.21	$-113.33	$-56.54	$-27.81
Shares Outstanding (M)	311M	300M	288M	254M	225M	204M	175M	153M	135M	106M	89M	76M	70M	63M	56M	54M	—	1M	1M	1M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PACB Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$39M	$37M	$45M	$38M	$40M	$37M	$39M	$40M
Gross Profit	$13M	$13M	$17M	$15M	$15M	($1M)	$10M	$10M
Gross Margin %	32.4%	34.5%	37.5%	39.2%	36.9%	-3.7%	25.6%	25.0%
Operating Income (EBIT)	($45M)	($38M)	($41M)	($39M)	($45M)	($429M)	($153M)	($64M)
Operating Margin %	-114.4%	-102.0%	-92.3%	-101.0%	-112.8%	-1154.5%	-390.1%	-160.3%
Net Income	($45M)	($8M)	($40M)	($38M)	($42M)	($426M)	$2M	($61M)
Net Margin %	-114.7%	-22.3%	-90.4%	-98.9%	-105.4%	-1146.8%	6.0%	-151.9%
EBITDA	($38M)	($6M)	($34M)	($31M)	($36M)	($52M)	$16M	($41M)
Earnings Per Share (EPS)	$-0.14	$-0.03	$-0.13	$-0.13	$-0.14	$-1.44	$0.01	$-0.22
Shares Outstanding (M)	311M	306M	302M	301M	300M	297M	307M	273M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PACB Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31
Cash from Operations (CFO)	($118M)	($111M)	($206M)	($267M)	($263M)	($111M)	$20M	($78M)	($66M)	($68M)	($68M)	($48M)	($51M)	($30M)	($77M)	($103M)	($122M)	($75M)	($38M)	($17M)
Capital Expenditures (CapEx)	$6M	$3M	$6M	$9M	$17M	$6M	$1M	$3M	$2M	$10M	$8M	$3M	$2M	$1M	$2M	$9M	$5M	$5M	$6M	$3M
Free Cash Flow (FCF)	($124M)	($114M)	($212M)	($275M)	($280M)	($117M)	$18M	($81M)	($68M)	($78M)	($76M)	($51M)	($53M)	($31M)	($79M)	($112M)	($127M)	($80M)	($44M)	($20M)
FCF Margin %	-78.0%	-71.2%	-137.8%	-137.3%	-218.3%	-89.7%	23.4%	-89.3%	-86.9%	-83.4%	-83.9%	-54.9%	-87.6%	-109.1%	-302.2%	-331.5%	-7601.9%	-59270.4%	-4884.1%	-914.5%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PACB Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	($35M)	($45M)	($19M)	($19M)	($29M)	($44M)	($31M)	($45M)
Capital Expenditures (CapEx)	$2M	$3M	$1M	$0M	$1M	$6M	$2M	$1M
Free Cash Flow (FCF)	($37M)	($48M)	($20M)	($19M)	($30M)	($50M)	($32M)	($46M)
FCF Margin %	-94.9%	-128.4%	-44.6%	-48.9%	-75.3%	-135.8%	-82.3%	-115.7%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PACB Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31
Total Assets	$752M	$784M	$1.3B	$1.7B	$1.8B	$2.0B	$414M	$148M	$170M	$144M	$138M	$131M	$125M	$136M	$130M	$218M	$306M	$101M	$113M
Cash & Cash Equivalents	$61M	$64M	$55M	$180M	$325M	$461M	$82M	$30M	$19M	$63M	$17M	$82M	$36M	$26M	$47M	$59M	$148M	$89M	$78M
Total Liabilities	$785M	$779M	$754M	$1.0B	$1.2B	$1.2B	$78M	$93M	$56M	$58M	$53M	$58M	$70M	$67M	$20M	$27M	$26M	$278M	$206M
Total Debt (Short + Long-Term)	$646M	$646M	$658M	$902M	$907M	$905M	$4M	$36M	$21M	$20M	$33M	$17M	$26M	$14M	$3M	$3M	$3M	$0M	$1M
Total Shareholders' Equity	($33M)	$5M	$507M	$701M	$563M	$791M	$335M	$55M	$114M	$86M	$85M	$74M	$55M	$69M	$109M	$191M	$280M	($177M)	($93M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PACB viewer.

Other Companies in MEDICAL DEVICES

QDEL · Quidel Corporation — $966 million
AHCO · Adapthealth Corp — $854 million
KIDS · Orthopediatrics Corp — $820 million
INMD · InMode Ltd — $810 million
VREX · Varex Imaging Corp — $787 million
CTKB · Cytek Biosciences Inc — $775 million
BVS · Bioventus Inc — $748 million
TCMD · Tactile Systems Technology Inc — $561 million

← PAC All “P” companies PACEDIGITK →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.